logo
logo
Sign in

Recent Trends In Stem Cell Therapy For CKD

avatar
Advancells
Recent Trends In Stem Cell Therapy For CKD

Summary: Transplants of the kidney are more in demand. High blood pressure and type II diabetes are on the rise in the western world and are associated with increased risks of renal damage. To address this expanding demand, however, there are not enough organ donors. Therapies using stem cells might provide an alternative.


Introduction

Regenerative medicine is the concept of employing living functional tissues to restore or replace functionally impaired organs. Stem cell treatment, in particular, is a novel emerging field of scientific inquiry and clinical application that shows promise for a wide range of disorders in both veterinary and human medicine. In recent years, there has been a surge of interest in the potential of adult stem cells to aid in the treatment of a variety of diseases, owing to both their regenerative properties and their evident capacity to change the environment in wounded and diseased tissues. Adult stem cells known as mesenchymal stem cells, in particular, can move to afflicted areas and could be capable of supporting the formation of other stem cells and controlling the response.


Stem Cells and Kidney Diseases

There have been various studies of stem cell therapy in animal models of renal failure, with most studies focusing on models of acute renal disease protection. The preponderance of these studies shows that systemic delivery of MSC generated from bone marrow or adipose tissue can assist retain renal function in acute shocks and can also help minimise tubular injury and fibrosis. Several investigations have also shown that limited numbers of MSC are incorporated into the renal parenchyma. Some of these MSC have been proposed to develop into functional renal tubular epithelial cells, albeit this notion is still contentious. Other researchers believe that the paracrine effects of the MSC injection are more significant than the effects of direct cellular integration into the kidney.   As a result, the existing results suggest that systemically delivered MSC can assist improve or stabilising renal function in acute renal illness through a variety of pathways.


MSC can create growth factors, cytokines, and anti-inflammatory mediators in vitro, which could promote to maintain or enhance renal function and suppress intra-renal inflammation. MSC suppressive ability appears to be regulated by both secreted substances and direct interaction with inflammatory cells. As a result, MSC can significantly decrease intrarenal inflammation.


Chronic Kidney Disease

CKD is a degenerative disease, and no treatment has been found to reverse or prevent deteriorating renal function for an extended period, short of kidney transplantation. This disease, which is characterised by tubulointerstitial injury, fibrosis, and gradual loss of renal function, is usually referred to as the ultimate common pathway following any of several forms of renal insults. Despite the initial damage, once a certain level of kidney damage is attained, progression is irreversible and tends to be consistent. 

The level of tubulointerstitial injury, including tubular atrophy, tubular glomeruli, and tubulointerstitial fibrosis, is connected to renal function impairment. Major variables hypothesised to contribute to tubulointerstitial injury include hyperfiltration, proteinuria, tubulointerstitial inflammation, oxidative damage, and activation of the renin-angiotensin-aldosterone system (RAAS). Based on findings from rodent model research, CKD stem cell treatment can improve or stabilise renal function in animals with renal failure. Understanding the biology of kidney disease could help researchers comprehend the cases.


Current  Research on Stem Cell Therapy For Kidney Diseases

Researchers are trying to come up with a strategy to augment kidney cells that promote organ regeneration. Researchers have recently pinpointed certain mesenchymal cells, a class of stem cells that are crucial for kidney recovery. These stem cells may be injected into the body to promote the repair of damaged kidney tissue and lower inflammatory levels generally. Additionally, the requirement for lifelong immunosuppressant medications has already been eliminated by using stem cells in combination with organ transplants.


Studying and treating kidney disease is difficult since the kidneys are intricate organs that provide crucial filtering activities for the body. Only generalized systemic stem cell therapy is now available to treat these conditions because researchers have not yet identified the precise cells in charge of kidney healing.


The considerable reduction in inflammatory markers relative to pre-treatment levels and a slight improvement in renal function would be reasonable outcomes of stem cell therapy. This probably wouldn't be enough to get a patient off of dialysis after just one treatment, but the goal would be to cut down on how often they needed it.


The Uptake

Since kidneys have such intricate architecture and such a wide variety of cells, it is particularly challenging to study renal development, kidney illness, and the natural repair process. Damage to several types of kidney cells can result in renal disorders. Stem cell therapies will only be successful if they take into account which cells need to be replaced due to damage. However, before treatments can be created, researchers still need a greater knowledge of how the natural repair mechanisms function. Cell treatments that support natural repair pathways may become available sooner than cell replacement therapies.



About the Company: Advancells is an Indian research-focused company that harnesses the power of stem cell research and technology. The primary objective of the company is to provide products and solutions for efficient therapeutic applications of regenerative medicine.

collect
0
avatar
Advancells
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more